Revenio Group Corporation, Managers’ transactions, October 13, 2022 at 10.30 a.m. (EEST)

 Revenio Group Oyj: Managers' Transactions – Kate Taylor

____________________________________________

Person subject to the notification requirement
Name: Kate Taylor
Position: Other senior manager

Issuer: Revenio Group Oyj
LEI: 743700I27E0FWSXLKK04
Notification type: INITIAL NOTIFICATION
Reference number: 20339/5/4
____________________________________________

Transaction date: 2022-10-11
Venue not applicable
Instrument type: SHARE
ISIN: FI0009010912
Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE

Transaction details
(1): Volume: 395 Unit price: 0 EUR
Aggregated transactions
(1): Volume: 395 Volume weighted average price: 0 EUR

For further information, please contact:
CFO Robin Pulkkinen, tel. +358 50 505 9932
robin.pulkkinen@revenio.fi
www.revenio.fi

DISTRIBUTION:
Nasdaq Helsinki Ltd
Main media
www.revenio.fi

Revenio Group in brief

Revenio is a leading company in the global market for ophthalmological devices and software solutions. Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as clinical software under the iCare brand. iCare is a trusted partner in ophthalmic diagnostics, offering physicians fast, easy-to-use, and reliable tools for the diagnosis of glaucoma, diabetic retinopathy, and macular degeneration (AMD). iCare Solutions provide digital clinical tools that drive greater efficiency and enhance quality in eye care.

In 2021, the Group’s net sales totaled EUR 78.8 million, with an operating profit of EUR 22.1 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.

Attachments

Revenio Group Corporation: Managers' Transactions – Kate Taylor

© Modular Finance, source Nordic Press Releases